Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc., has signed a 12-month software development and technology services agreement with Flash Sports & Media Holdings, Inc. to build and operate FlashChain, a blockchain designed to track digital broadcasting rights, video assets and match ticket inventory. The agreement positions MindWave to deploy a dedicated FlashChain subnet on its MindChain Layer-2 infrastructure, operate validator nodes and develop software connecting Flash streaming and ticketing platforms and gate-scanning hardware to the network.
Under the agreement, MindWave will also develop smart contracts to authenticate digital match tickets, manage digital sports memorabilia and help prevent ticket counterfeiting and unauthorized duplication of media. This matters because it addresses two persistent pain points in the sports and entertainment industry: ticket fraud and unauthorized redistribution of broadcast content. By moving these functions onto a dedicated blockchain subnet, the parties aim to create a transparent, traceable and verifiable record of digital assets, which could reduce revenue leakage for rights holders and improve trust for fans and partners.
MindWave will receive Flash Sports & Media Holdings common shares and an allocation equal to 20% of the total supply of FLASH TOKEN, along with an annual maintenance fee equal to 50% of applicable contract consideration. The parties have not publicly disclosed the aggregate dollar value of the agreement. The token allocation and equity component suggest that MindWave is not merely a vendor but a stakeholder in the success of FlashChain, aligning its incentives with the long-term adoption of the network.
The deal also expands the commercial reach of MindChain, which is described as a blockchain infrastructure developed within the MindWave ecosystem to support transparent, traceable and verifiable digital transactions. FlashChain will run as a dedicated, independently branded subnet on MindChain’s Layer-2 infrastructure and may participate in MindChain’s insurance program, subject to its coverage terms. That insurance angle could be a differentiator if it helps attract institutional participants who require risk mitigation before committing to blockchain-based asset registries.
Beyond this agreement, MindWave is developing enterprise blockchain infrastructure and institutional technology platforms through its MindChain ecosystem. Four ecosystems operate under MindChain: InsurTech through BlockAssure, which is developing a Bermuda-framework platform applying Bitcoin reserves as regulatory capital to support life and property and casualty underwriting; ClimateTech through AQUAE and the ALCI index, measuring, verifying and tokenizing ecosystem services into institutional-grade assets; HealthTech through the Apitox development program; and RWA Tech through Nexus Global Partners, bringing institutional real estate on-chain within a compliance-first, insurance-enhanced framework. The breadth of these initiatives indicates that Apimeds is attempting to build a multi-sector blockchain platform rather than a single-purpose application.
For investors, the FlashChain agreement provides a concrete commercial use case for MindChain and a potential new revenue stream for Apimeds. To view the full press release, visit https://ibn.fm/LD2UM. The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS.
TechMediaWire TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire and other services. For more information, please visit https://www.TechMediaWire.com. Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer.
